Simultaneous EVs and cfDNA isolation
for Super-Resolution liquid biopsy

Hermes Biosciences has developed an automated benchtop system that isolates EVs and cfDNA together from a single plasma draw.

​

More signals from EVs and cfDNA. Capturing biology from different physiological states.

​

More data from combined biomarkers. Integrating cfDNA and EV biomarkers produces the data needed to uncover disease processes earlier and more precisely.

​

More chances to detect and manage disease. Higher sensitivity and specificity could lead to earlier diagnosis and better treatment choices for patients with cancer and degenerative conditions.